Efficacy and Safety of LBH589 in Adult Patients With Refractory Chronic Myeloid Leukemia (CML) in Chronic Phase
Status:
Terminated
Trial end date:
2008-09-30
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy and safety of LBH589B in adult patients with chronic
phase chronic myeloid leukemia with resistant disease following treatment with at least two
BCR-ABL tyrosine kinase inhibitors